circulating tumor cells in management of patients with castration-resistant prostate cancer
Published 2 years ago • 102 plays • Length 0:33Download video MP4
Download video MP3
Similar videos
-
30:17
circulating tumor cells in prostate cancer - the premise and the promise
-
2:35
circulating tumor cells as a treatment monitoring tool in metastatic breast cancer
-
0:31
unmet needs in the use of circulating tumor cells for prostate cancer
-
1:15
updates in the treatment of castration-resistant prostate cancer
-
1:30
bmi and clinical outcomes in patients with metastatic castration-resistant prostate cancer
-
0:39
stereotactic body rt in patients with oligometastatic crpc undergoing 1l treatment with abiraterone
-
5:46
metastatic castration-resistant prostate cancer – new learnings and perspectives
-
3:56
ctc enumeration as a prognostic biomarker in prostate cancer
-
1:30
how far away are we from implementing ctc-based approaches in prostate cancer?
-
4:31
clinical implications of ctcs in prostate cancer – are they the best thing to measure?
-
1:25
treatment options in castration resistant prostate cancer
-
3:07
current developments in castration-resistant prostate cancer therapies
-
0:50
how can sequential therapy be used in castration-resistant prostate cancer?
-
1:47
clinical applications of circulating tumor cells
-
27:54
castration resistant prostate cancer
-
8:45
clinical trials in nonmetastatic castration-resistant prostate cancer
-
2:29
nccn guidelines for patients with castration-resistant metastatic prostate cancer
-
1:19
highlights in prostate cancer from esmo
-
1:29
evaluating the role of sbrt in metastatic castrate-resistant prostate cancer